CEF treated group showed an attenuation of TBI-induced cerebral edema and functional cognitive impairments.  CEF administration also decreased the levels of proinflammatory cytokines interleukin-1β, interferon-γ, and TNF-α.  It also up-regulated the expression of GLT-1 level after TBI. The gene discussed is SLC1A2; the disease is brain edema.